Synovial sarcoma: current view of pathogenesis and therapeutic approaches

Synovial sarcoma is characterized by a typical transcript SS18::SSX. However, despite a common pathogenesis and similar therapeutic approaches, opposite responses to therapy are sometimes observed. Supposedly, this can be associated with additional and alternative pathways of genetic and epigenetic regulation. In this review, the problems of synovial sarcoma diagnosis, pathogenesis and new therapy methods, including targeting epigenetics, are discussed. © 2025, ABV-press Publishing House. All rights reserved.

Авторы
Senchenko Maria Anatolevna 1, 2 , Tararykova Anastasia Alekseevna 1 , Kozlov Nikolai A. 1 , Fetisov Timur I. 3 , Kirsanov Kirill 3 , Rogozhin Dmitrii Viktorovich 1, 4
Номер выпуска
3
Язык
Russian
Страницы
26-37
Статус
Published
Том
17
Год
2025
Организации
  • 1 Blokhin National Medical Research Center of Oncology, Ministry of Health, Moscow, Russian Federation
  • 2 Ministry of Health of Russian Federation, Moscow, Moscow Oblast, Russian Federation
  • 3 RUDN University, Moscow, Moscow Oblast, Russian Federation
  • 4 Pirogov Russian National Research Medical University (RNRMU), Moscow, Russian Federation
Ключевые слова
adoptive cell therapy; checkpoint inhibitor; soft tissue sarcoma; synovial sarcoma; tyrosine kinase inhibitor
Цитировать
Поделиться

Другие записи